EBITDA Summary of Apex Biotechnology Corp.

Apex Biotechnology Corp.'s latest annual EBITDA in 2023 was 221.06 Million TWD , down -25.48% from previous year.
Apex Biotechnology Corp.'s latest quarterly EBITDA in 2024 Q2 was 33.2 Million TWD , down -33.45% from previous quarter.
Apex Biotechnology Corp. reported an annual EBITDA of 299.07 Million TWD in 2022, up 3.25% from previous year.
Apex Biotechnology Corp. reported an annual EBITDA of 289.64 Million TWD in 2021, up 28.32% from previous year.
Apex Biotechnology Corp. reported a quarterly EBITDA of 32.99 Million TWD for 2024 Q1, up 59.13% from previous quarter.
Apex Biotechnology Corp. reported a quarterly EBITDA of 31.36 Million TWD for 2023 Q4, down -54.06% from previous quarter.

Annual EBITDA Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual EBITDA of Apex Biotechnology Corp. (2023 - 2009)

Year	EBITDA	EBITDA Growth
2023	221.06 Million TWD	-25.48%
2022	299.07 Million TWD	3.25%
2021	289.64 Million TWD	28.32%
2020	225.72 Million TWD	-21.92%
2019	289.1 Million TWD	3.86%
2018	278.35 Million TWD	20.55%
2017	230.89 Million TWD	41.26%
2016	163.45 Million TWD	-62.31%
2015	434.39 Million TWD	-1.75%
2014	441.47 Million TWD	-16.69%
2013	550.93 Million TWD	-22.81%
2012	687.15 Million TWD	0.02%
2011	679.58 Million TWD	14.0%
2010	603.22 Million TWD	18.99%
2009	489.1 Million TWD	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	33.2 Million TWD	-33.45%
2024 Q1	32.99 Million TWD	59.13%
2023 Q4	31.36 Million TWD	-54.06%
2023 Q2	53.55 Million TWD	-21.09%
2023 FY	- TWD	-25.48%
2023 Q1	67.87 Million TWD	0.08%
2023 Q3	68.26 Million TWD	27.46%
2022 Q3	95.75 Million TWD	83.89%
2022 FY	- TWD	3.25%
2022 Q1	83.41 Million TWD	-0.12%
2022 Q4	67.82 Million TWD	-29.17%
2022 Q2	52.07 Million TWD	-37.58%
2021 FY	- TWD	28.32%
2021 Q3	85.84 Million TWD	51.72%
2021 Q1	67.2 Million TWD	1.8%
2021 Q4	83.51 Million TWD	-2.71%
2021 Q2	56.57 Million TWD	-15.82%
2020 Q2	53.95 Million TWD	10.64%
2020 Q1	48.76 Million TWD	-63.96%
2020 Q4	66.02 Million TWD	15.86%
2020 FY	- TWD	-21.92%
2020 Q3	56.98 Million TWD	5.61%
2019 Q3	16.58 Million TWD	-77.66%
2019 FY	- TWD	3.86%
2019 Q1	62.98 Million TWD	8275.93%
2019 Q2	74.23 Million TWD	17.85%
2019 Q4	135.3 Million TWD	715.92%
2018 Q2	88.53 Million TWD	58.62%
2018 FY	- TWD	20.55%
2018 Q3	133.25 Million TWD	50.52%
2018 Q1	55.81 Million TWD	-38.85%
2018 Q4	752 Thousand TWD	-99.44%
2017 Q4	91.26 Million TWD	50.52%
2017 Q1	-12.41 Million TWD	85.34%
2017 Q3	60.63 Million TWD	-33.66%
2017 FY	- TWD	41.26%
2017 Q2	91.4 Million TWD	836.03%
2016 Q4	-84.69 Million TWD	-387.55%
2016 FY	- TWD	-62.31%
2016 Q1	110.69 Million TWD	-8.76%
2016 Q2	107.99 Million TWD	-2.44%
2016 Q3	29.45 Million TWD	-72.73%
2015 Q3	161.04 Million TWD	107.07%
2015 FY	- TWD	-1.75%
2015 Q1	73.59 Million TWD	-43.3%
2015 Q2	77.77 Million TWD	5.67%
2015 Q4	121.32 Million TWD	-24.66%
2014 Q1	102.25 Million TWD	42.16%
2014 Q4	129.8 Million TWD	23.03%
2014 Q3	105.5 Million TWD	1.53%
2014 Q2	103.91 Million TWD	1.62%
2014 FY	- TWD	-16.69%
2013 Q3	86.62 Million TWD	-57.13%
2013 Q4	71.93 Million TWD	-16.97%
2013 FY	- TWD	-22.81%
2013 Q1	169.32 Million TWD	8.09%
2013 Q2	202.04 Million TWD	19.33%
2012 Q2	193.79 Million TWD	2.92%
2012 FY	- TWD	0.02%
2012 Q3	150.83 Million TWD	-22.17%
2012 Q1	188.29 Million TWD	-1.8%
2012 Q4	156.64 Million TWD	3.86%
2011 Q4	191.74 Million TWD	-14.01%
2011 Q1	122.58 Million TWD	-3.03%
2011 Q3	222.98 Million TWD	49.6%
2011 FY	- TWD	14.0%
2011 Q2	149.05 Million TWD	21.59%
2010 Q2	164.29 Million TWD	14.07%
2010 Q4	126.41 Million TWD	-24.45%
2010 Q1	144.03 Million TWD	0.0%
2010 FY	- TWD	18.99%
2010 Q3	167.32 Million TWD	1.84%
2009 FY	- TWD	0.0%

Peer EBITDA Comparison of Apex Biotechnology Corp.

Name	EBITDA	EBITDA Difference
Sinphar Pharmaceutical Co.,Ltd.	582.94 Million TWD	62.079%
Panion & Bf Biotech Inc.	327.21 Million TWD	32.443%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	473.81 Million TWD	53.345%
GenMont Biotech Incorporation	71.76 Million TWD	-208.02%
Abnova (Taiwan) Corporation	81.2 Million TWD	-172.211%
Adimmune Corporation	-512.42 Million TWD	143.14%
Tanvex BioPharma, Inc.	-1.75 Billion TWD	112.6%
Polaris Group	-1.38 Billion TWD	115.909%
Energenesis Biomedical CO.,LTD.	-244.57 Million TWD	190.385%
UnicoCell Biomed Co., Ltd.	-56.27 Million TWD	492.814%
PELL Bio-Med Technology Co. Ltd.	-353.17 Million TWD	162.592%

Global Stocks Search

Apex Biotechnology Corp. (1733.TW)

EBITDA Summary of Apex Biotechnology Corp.

Annual EBITDA Chart of Apex Biotechnology Corp. (2023 - 2009)

Historical Annual EBITDA of Apex Biotechnology Corp. (2023 - 2009)

Peer EBITDA Comparison of Apex Biotechnology Corp.